Skip to main content

"Drosophila" is consolidated as a valid model in cancer and autoimmune syndromes

Participants

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255

The "Diario Médico" reports on statements by Marco Milán on the uses of Drosophila melanogaster to study diseases such as cancer and autoimmune conditions. Milán coorganised the European Drosophila Research Congress, which was held in Barcelona from 16 to 19 October.

Read the news in "Diario Médico" (PDF in Spanish)

Related news:

Barcelona hosts major European conference on Drosophila research

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).